BAC
Bank of America Corporation
BAC has a slight edge over EWBC overall, supported by stronger valuation and stronger modeled upside.
EWBC
East West Bancorp, Inc.
EWBC's outlook is improving, though it still trails on the overall score.
BAC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
BAC's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BAC.
EWBC Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Strong | |
| N/A | |
| N/A |
EWBC's profitability is currently strong, and its revenue is stable. Free cash flow and net leverage aren't meaningful measures for financial services companies like EWBC.
BAC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.4x | $39.50 | -22% |
| Forward | 10x | $50.51 | — |
| Current | 12x | $50.51 | — |
| Fair | 13x | $53.81 | +6.5% |
| Expensive | 15x | $62.23 | +23% |
Historical ranges are pointers, not guarantees.
BAC has the edge over EWBC in the historical PE scenario, which offers more potential upside but is not a forecast.
EWBC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 8x | $84.09 | -36% |
| Fair | 11x | $115 | -13% |
| Forward | 11x | $131 | — |
| Current | 12x | $131 | — |
| Expensive | 13x | $141 | +7.8% |
Historical ranges are pointers, not guarantees.
EWBC's PE is in its expensive range at 12x. If earnings grow as analysts expect, today's price would be 11x next year's earnings, in its fair range.
BAC Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
BAC has the edge over EWBC on the outlook, with more favorable profitability expectations.
EWBC Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Stable | |
| Limited | |
| Low |
Analysts expect earnings and revenue growth for EWBC, with profitability holding steady. However, they disagree widely on these estimates.
BAC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.92 | +17% |
| Q3 2026 | $4.19 | +14% |
| Q2 2026 | $4.34 | +27% |
| Q1 2026 | $4.02 | +20% |
| Q4 2025 | $3.81 | +19% |
| Q3 2025 | $3.66 | +33% |
| Q2 2025 | $3.41 | +20% |
| Q1 2025 | $3.35 | +16% |
| Q4 2024 | $3.21 | +4.2% |
BAC has the edge over EWBC on earnings, with stronger typical year-over-year growth.
EWBC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $11.47 | +9.1% |
| Q3 2026 | $10.51 | +16% |
| Q2 2026 | $10.40 | +21% |
| Q1 2026 | $10.01 | +19% |
| Q4 2025 | $9.52 | +14% |
| Q3 2025 | $9.07 | +15% |
| Q2 2025 | $8.56 | +9.7% |
| Q1 2025 | $8.38 | +5.5% |
| Q4 2024 | $8.33 | +1.8% |
EWBC's earnings per share have climbed steadily: $10.51 over the past year, up 16% from the year before, and higher year over year for eight quarters in a row.
BAC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $30B | +6.7% |
| Q2 2026 | $31.6B | +19% |
| Q1 2026 | $30.3B | +11% |
| Q4 2025 | $31.2B | +23% |
| Q3 2025 | $28.1B | +11% |
| Q2 2025 | $26.5B | +4.3% |
| Q1 2025 | $27.4B | +6% |
| Q4 2024 | $25.3B | +15% |
BAC's revenue has grown year over year for 10 quarters in a row: $30B last quarter, up 6.7% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 30% | -3.7 points |
| Q2 2026 | 37% | +7.6 points |
| Q1 2026 | 34% | +4.7 points |
| Q4 2025 | 40% | +12 points |
| Q3 2025 | 34% | +4.8 points |
| Q2 2025 | 29% | -0.7 points |
| Q1 2025 | 30% | +1.5 points |
| Q4 2024 | 28% | +14 points |
BAC's operating margin was 30% last quarter, down 3.7 points from the same quarter a year ago.
EWBC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $822.7M | +5.7% |
| Q2 2026 | $791.1M | +12% |
| Q1 2026 | $773.7M | +12% |
| Q4 2025 | $758.3M | +12% |
| Q3 2025 | $778M | +18% |
| Q2 2025 | $703.3M | +10% |
| Q1 2025 | $692.3M | +7.5% |
| Q4 2024 | $674.4M | +3% |
EWBC has the edge over BAC on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 60% | +0.4 points |
| Q2 2026 | 59% | +1.9 points |
| Q1 2026 | 59% | +2.6 points |
| Q4 2025 | 62% | +8.8 points |
| Q3 2025 | 60% | +0.6 points |
| Q2 2025 | 57% | +0.1 points |
| Q1 2025 | 57% | -1.3 points |
| Q4 2024 | 53% | +2.8 points |
EWBC has the edge over BAC on profitability, with a higher operating margin.
BAC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$6.5B | -114% |
| Q2 2026 | $29B | +$38.2B |
| Q1 2026 | $41.8B | +$44B |
| Q4 2025 | -$22.9B | -189% |
| Q3 2025 | $46.9B | +$84.2B |
| Q2 2025 | -$9.1B | -150% |
| Q1 2025 | -$2.2B | +$13.4B |
| Q4 2024 | $25.9B | -21% |
BAC's free cash flow was $41.4B over the past year, down 33% from the year before. Free cash flow isn't a meaningful measure for financial services companies like BAC.
EWBC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $450.5M | +94% |
| Q2 2026 | $587.9M | +111% |
| Q1 2026 | $329.6M | +19% |
| Q4 2025 | $713.4M | +43% |
| Q3 2025 | $231.7M | -40% |
| Q2 2025 | $278.7M | +7.5% |
| Q1 2025 | $277.9M | +4.4% |
| Q4 2024 | $500.1M | -11% |
EWBC has the edge over BAC on cash flow, with more consistent year-over-year improvement.
BAC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1% | -72M shares |
| 1 year | -5.3% | -405M shares |
| 3 years | -11% | -854M shares |
| 5 years | -15% | -1.3B shares |
| Available history | -24% | -2.2B shares |
BAC has the edge over EWBC on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $6B |
| Q2 2026 | $6B |
| Q1 2026 | $7.2B |
| Q4 2025 | $6.3B |
| Q3 2025 | $5.3B |
| Q2 2025 | $5.3B |
| Q1 2025 | $4.5B |
| Q4 2024 | $3.5B |
BAC spent $25.6B buying back its own shares over the past year, up 37% from the year before.
EWBC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.1% | +160K shares |
| 1 year | -0.3% | -481K shares |
| 3 years | -2.6% | -3.7M shares |
| 5 years | -3.3% | -4.7M shares |
| Available history | -5.4% | -7.9M shares |
EWBC has 138M diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | $669,000 |
| Q2 2026 | $1,000 |
| Q1 2026 | $97.8M |
| Q4 2025 | $1M |
| Q3 2025 | $25.4M |
| Q2 2025 | $3.7M |
| Q1 2025 | $85.4M |
| Q4 2024 | $19.9M |
EWBC spent $100M buying back its own shares over the past year, down 26% from the year before.
BAC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 6.4x | High |
| Q2 2026 | 6.7x | High |
| Q1 2026 | 7.1x | High |
| Q4 2025 | 7.7x | High |
| Q3 2025 | 8.3x | High |
| Q2 2025 | 8.8x | High |
| Q1 2025 | 8.6x | High |
| Q4 2024 | 9.0x | High |
BAC's net debt is about 6.4 years of its operating earnings (EBITDA), down from 8.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like BAC.
EWBC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -2.2x | Net Cash |
| Q2 2026 | -2.5x | Net Cash |
| Q1 2026 | -2.2x | Net Cash |
| Q4 2025 | -2.1x | Net Cash |
| Q3 2025 | -2.5x | Net Cash |
| Q2 2025 | -2.5x | Net Cash |
| Q1 2025 | -2.0x | Net Cash |
| Q4 2024 | -3.1x | Net Cash |
EWBC has the edge over BAC on leverage, with a lower net debt burden relative to earnings.
BAC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.1 | Neutral |
| Stochastic | 4.9 | Oversold |
BAC's weekly RSI is 37 (neutral) and its Stochastic is 5 (oversold).
EWBC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.0 | Neutral |
| Stochastic | 56.4 | Neutral |
EWBC's weekly RSI is 57 (neutral) and its Stochastic is 56 (neutral).
BAC PE vs Financial Services Sector
| Metric | BAC | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 7.5% below |
| PE % | 40 | 63 | 23 pts below |
BAC has the edge over EWBC on valuation relative to its sector.
EWBC PE vs Financial Services Sector
| Metric | EWBC | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 4.1% below |
| PE % | 69 | 63 | 6 pts above |
EWBC is trading at 12x earnings, in line with the Financial Services sector's median of 13x.
BAC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $52.1 | 3% below |
| 20 week MA | $57.8 | 13% below |
| 50 week MA | $54.7 | 7.7% below |
| 100 week MA | $50.5 | 0% below |
| 200 week MA | $42.5 | 19% above |
BAC has fallen below most of its moving averages, though it's still 19% above its 200-week average.
EWBC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $128.5 | 2.1% above |
| 20 week MA | $130.0 | 0.9% above |
| 50 week MA | $122.2 | 7.3% above |
| 100 week MA | $109.8 | 19% above |
| 200 week MA | $89.9 | 46% above |
EWBC has the edge over BAC on trend strength, trading above more of its moving averages.
BAC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $35.4 | $30.0 | -15% |
| 2021 | $30.0 | $44.4 | +48% |
| 2022 | $44.4 | $32.5 | -27% |
| 2023 | $32.5 | $33.7 | +3.7% |
| 2024 | $33.7 | $44.3 | +32% |
| 2025 | $44.3 | $56.2 | +27% |
| 2026 YTD | $56.2 | $50.5 | -10% |
BAC has finished higher in four of the last six years. It's down 10% so far in 2026.
EWBC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $48.8 | $50.4 | +3.3% |
| 2021 | $50.4 | $77.4 | +54% |
| 2022 | $77.4 | $64.9 | -16% |
| 2023 | $64.9 | $72.0 | +11% |
| 2024 | $72.0 | $96.7 | +34% |
| 2025 | $96.7 | $116.0 | +20% |
| 2026 YTD | $116.0 | $131.2 | +13% |
EWBC has the edge over BAC on returns for 2026, with the stronger performance.